Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Paulien G. de Jong"'
Autor:
Siobhan Quenby, Katie Booth, Louise Hiller, Arri Coomarasamy, Eva Hamulyák, Luuk Scheres, Paulien G. de Jong, Thijs van Haaps, Lauren J. Ewington, Shreeya Tewary, Mariëtte Goddijn, Saskia Middeldorp
Publikováno v:
Blood. 140:LBA-5
Autor:
Saskia Middeldorp, Luuk J. J. Scheres, Mariska M.G. Leeflang, M. Nijkeuter, Thijs E. van Mens, Paulien G. de Jong
Publikováno v:
The Cochrane Library
Background Pulmonary embolism is a leading cause of pregnancy-related death. An accurate diagnosis in pregnant patients is crucial to prevent untreated pulmonary embolism as well as unnecessary anticoagulant treatment and future preventive measures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5085b983a2a169a916f507549a8b5429
https://doi.org/10.1002/14651858.cd011053.pub2
https://doi.org/10.1002/14651858.cd011053.pub2
Autor:
Évelyne Rey, Saskia Middeldorp, Jean-Christophe Gris, Risto Kaaja, Alain Mayhew, Marc A. Rodger, Carolien N H Abheiden, Ranjeeta Mallick, Paulien G. de Jong, David Petroff, Nicole Langlois, P. Dick Bezemer, Johanna I.P. de Vries, Shannon M. Bates, Ekkehard Schleussner, Annalisa Perna, Tim Ramsay, Ida Martinelli, Marion E. van Hoorn
Publikováno v:
Obstetrical & gynecological survey, 72(3), 153-155. Lippincott Williams and Wilkins
The Lancet
The Lancet, Elsevier, 2016, 388 (10060), pp.2629-2641. ⟨10.1016/S0140-6736(16)31139-4⟩
Lancet, 388(10060), 2629-2641. Elsevier Limited
Rodger, M A, Gris, J C, De Vries, J I P, Martinelli, I, Rey, É, Schleussner, E, Middeldorp, S, Kaaja, R, Langlois, N J, Ramsay, T, Mallick, R, Bates, S M, Abheiden, C N H, Perna, A, Petroff, D, De Jong, P, Van Hoorn, M E, Bezemer, P D & Mayhew, A D 2017, ' Low-Molecular-Weight Heparin and Recurrent Placenta-Mediated Pregnancy Complications : A Meta-analysis of Individual Patient Data from Randomised Controlled Trials ', Obstetrical and Gynecological Survey, vol. 72, no. 3, pp. 153-155 . https://doi.org/10.1097/01.ogx.0000513226.69777.83
Rodger, M A, Gris, J-C, de Vries, J I P, Martinelli, I, Rey, E, Schleussner, E, Middeldorp, S, Kaaja, R, Langlois, N J, Ramsay, T, Mallick, R, Bates, S M, Abheiden, C N H, Perna, A, Petroff, D, de Jong, P, van Hoorn, M E, Bezemer, P D & Mayhew, A D 2016, ' Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials ', Lancet, vol. 388, no. 10060, pp. 2629-2641 . https://doi.org/10.1016/S0140-6736(16)31139-4
Obstetrical and Gynecological Survey, 72(3), 153-155. Lippincott Williams and Wilkins
The Lancet
The Lancet, Elsevier, 2016, 388 (10060), pp.2629-2641. ⟨10.1016/S0140-6736(16)31139-4⟩
Lancet, 388(10060), 2629-2641. Elsevier Limited
Rodger, M A, Gris, J C, De Vries, J I P, Martinelli, I, Rey, É, Schleussner, E, Middeldorp, S, Kaaja, R, Langlois, N J, Ramsay, T, Mallick, R, Bates, S M, Abheiden, C N H, Perna, A, Petroff, D, De Jong, P, Van Hoorn, M E, Bezemer, P D & Mayhew, A D 2017, ' Low-Molecular-Weight Heparin and Recurrent Placenta-Mediated Pregnancy Complications : A Meta-analysis of Individual Patient Data from Randomised Controlled Trials ', Obstetrical and Gynecological Survey, vol. 72, no. 3, pp. 153-155 . https://doi.org/10.1097/01.ogx.0000513226.69777.83
Rodger, M A, Gris, J-C, de Vries, J I P, Martinelli, I, Rey, E, Schleussner, E, Middeldorp, S, Kaaja, R, Langlois, N J, Ramsay, T, Mallick, R, Bates, S M, Abheiden, C N H, Perna, A, Petroff, D, de Jong, P, van Hoorn, M E, Bezemer, P D & Mayhew, A D 2016, ' Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials ', Lancet, vol. 388, no. 10060, pp. 2629-2641 . https://doi.org/10.1016/S0140-6736(16)31139-4
Obstetrical and Gynecological Survey, 72(3), 153-155. Lippincott Williams and Wilkins
International audience; BACKGROUND:Placenta-mediated pregnancy complications include pre-eclampsia, late pregnancy loss, placental abruption, and birth of a small-for-gestational-age (SGA) neonate. These complications are leading causes of maternal,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faade1b2b461d2d127c441e66f7855c9
https://pure.amc.nl/en/publications/lowmolecularweight-heparin-and-recurrent-placentamediated-pregnancy-complications-a-metaanalysis-of-individual-patient-data-from-randomised-controlled-trials(ea981548-260a-42ae-8b3e-aef95e40c7b4).html
https://pure.amc.nl/en/publications/lowmolecularweight-heparin-and-recurrent-placentamediated-pregnancy-complications-a-metaanalysis-of-individual-patient-data-from-randomised-controlled-trials(ea981548-260a-42ae-8b3e-aef95e40c7b4).html
Publikováno v:
British Journal of Haematology. 158:433-441
Summary Venous thromboembolism (VTE) is effectively treated with anticoagulant therapy. After an initial treatment phase, extended treatment is effective to prevent recurrence after a first event but this is at the expense of a continued risk of blee
Autor:
C.A.M. Koks, Helen L. Torrance, Maria T. DeSancho, Walter K. H. Kuchenbecker, Paulien G. de Jong, Barbara A. Hutten, Annemieke Hoek, Harold R. Verhoeve, Johanna Inge Petra de Vries, Arri Coomarasamy, Kristin Jochmans, Jantien Visser, Siobhan Quenby, Babette A. M. Braams-Lisman, Hubertina C.J. Scheepers, Jan Bruin, Olivier W.H. van der Heijden, Ben W.J. Mol, Saskia Middeldorp, Mariëtte Goddijn, Mary D. Stephenson, Kitty W.M. Bloemenkamp, Michèle David
Publikováno v:
Trials
Trials, 16:208. BioMed Central Ltd
TRIALS, 16:208. BMC
Trials, 16(1). BioMed Central
Trials, 16
Trials, 16. BioMed Central
Trials [E], 16(1). BioMed Central
de Jong, P G, Quenby, S, Bloemenkamp, K W M, Braams-Lisman, B A M, de Bruin, J P, Coomarasamy, A, David, M, DeSancho, M T, van der Heijden, O W H, van Hoek, A, Hutten, B A, Jochmans, K, Koks, C A M, Kuchenbecker, W K H, Mol, B J, Torrance, H L, Scheepers, H C J, Stephenson, M D, Verhoeve, H R, Visser, J, Vries, J I P, Goddijn, M & Middeldorp, S 2015, ' ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia-study protocol for a randomized controlled trial ', Trials, vol. 16, pp. 208 . https://doi.org/10.1186/s13063-015-0719-9
Trials, 16:208. BioMed Central Ltd
TRIALS, 16:208. BMC
Trials, 16(1). BioMed Central
Trials, 16
Trials, 16. BioMed Central
Trials [E], 16(1). BioMed Central
de Jong, P G, Quenby, S, Bloemenkamp, K W M, Braams-Lisman, B A M, de Bruin, J P, Coomarasamy, A, David, M, DeSancho, M T, van der Heijden, O W H, van Hoek, A, Hutten, B A, Jochmans, K, Koks, C A M, Kuchenbecker, W K H, Mol, B J, Torrance, H L, Scheepers, H C J, Stephenson, M D, Verhoeve, H R, Visser, J, Vries, J I P, Goddijn, M & Middeldorp, S 2015, ' ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia-study protocol for a randomized controlled trial ', Trials, vol. 16, pp. 208 . https://doi.org/10.1186/s13063-015-0719-9
Background A large number of studies have shown an association between inherited thrombophilia and recurrent miscarriage. It has been hypothesized that anticoagulant therapy might reduce the number of miscarriages and stillbirth in these women. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77eda61d36298f1ae48f626a68578d32
https://doi.org/10.1186/s13063-015-0719-9
https://doi.org/10.1186/s13063-015-0719-9
Autor:
Paulien G. de Jong, Lambertus A. Kiemeney, Waander L. van Heerde, Larissa Hiddink, Joost C. M. Meijers, Saskia Middeldorp
Publikováno v:
British journal of haematology, 169(2), 301-304. Wiley-Blackwell
British Journal of Haematology, 169, 2, pp. 301-4
British Journal of Haematology, 169, 301-4
British Journal of Haematology, 169, 2, pp. 301-4
British Journal of Haematology, 169, 301-4
Item does not contain fulltext
Publikováno v:
The Cochrane Library
Background Since hypercoagulability might result in recurrent miscarriage, anticoagulant agents could potentially increase the chance of live birth in subsequent pregnancies in women with unexplained recurrent miscarriage, with or without inherited t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fcb5b32c3761428f2a6000a4d584ee2
https://doi.org/10.1002/14651858.cd004734.pub4
https://doi.org/10.1002/14651858.cd004734.pub4
Autor:
David Petroff, Ida Martinelli, Tim Ramsay, Risto Kaaja, Nicole Langlois, Ranjeeta Mallick, Marion E. van Hoorn, Dick Bezemer, Jean-Christophe Gris, Saskia Middeldorp, Marc A. Rodger, Paulien G. de Jong, Evelyne Rey, Johanna I.P. de Vries, Shannon M. Bates, Ekkehard Schleussner, Annalisa Perna, Carolien N H Abheiden, Becky Skidmore
Publikováno v:
Systematic Reviews
Systematic Reviews, BioMed Central, 2014, 3, pp.69. ⟨10.1186/2046-4053-3-69⟩
Rodger, M A, Langlois, N J, Vries, J I P, Rey, E, Gris, J C, Martinelli, E, Schleussner, E, Ramsay, T, Mallick, R, Skidmore, B, Middeldorp, S, Bates, S E, Petroff, D, Bezemer, P D, van Hoorn, M E, Abheiden, C N H, Perna, A, de Jong, P & Kaaja, R 2014, ' Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM) ', Systematic Reviews, vol. 3, 69 . https://doi.org/10.1186/2046-4053-3-69
Systematic Reviews, 3:69. BioMed Central
Systematic reviews, 3(1). BioMed Central
Systematic Reviews, BioMed Central, 2014, 3, pp.69. ⟨10.1186/2046-4053-3-69⟩
Rodger, M A, Langlois, N J, Vries, J I P, Rey, E, Gris, J C, Martinelli, E, Schleussner, E, Ramsay, T, Mallick, R, Skidmore, B, Middeldorp, S, Bates, S E, Petroff, D, Bezemer, P D, van Hoorn, M E, Abheiden, C N H, Perna, A, de Jong, P & Kaaja, R 2014, ' Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM) ', Systematic Reviews, vol. 3, 69 . https://doi.org/10.1186/2046-4053-3-69
Systematic Reviews, 3:69. BioMed Central
Systematic reviews, 3(1). BioMed Central
International audience; BACKGROUND: Placenta-mediated pregnancy complications include pre-eclampsia, late pregnancy loss, placental abruption, and the small-for-gestational age newborn. They are leading causes of maternal, fetal, and neonatal morbidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a49b4815bb745319cdf89c6f41b25cb
https://hal.umontpellier.fr/hal-01945886/document
https://hal.umontpellier.fr/hal-01945886/document
Autor:
Saskia Middeldorp, Claudia R. Kowalik, Mariëtte Goddijn, Rosa Vissenberg, Paulien G. de Jong, Emmy van den Boogaard
Publikováno v:
De Jong, P G, Van Den Boogaard, E, Kowalik, C R, Vissenberg, R, Middeldorp, S & Goddijn, M 2013, Which Investigations are Relevant? in Recurrent Pregnancy Loss . Wiley-Blackwell, pp. 10-28 . https://doi.org/10.1002/9781118749012.ch2
Recurrent Pregnancy Loss
Recurrent Pregnancy Loss, 10-28
STARTPAGE=10;ENDPAGE=28;TITLE=Recurrent Pregnancy Loss
Recurrent Pregnancy Loss
Recurrent Pregnancy Loss, 10-28
STARTPAGE=10;ENDPAGE=28;TITLE=Recurrent Pregnancy Loss
Potential risk factors for a subsequent miscarriage can be identified in women with preceding recurrent miscarriage (RM). Presently, many diagnostic interventions for women or couples with RM are controversial because there is no information availabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc7a29f48635d36f3cb0de061b1747e
https://doi.org/10.1002/9781118749012.ch2
https://doi.org/10.1002/9781118749012.ch2